challenges of selecting frontline therapy in cll
Published 3 years ago • 149 plays • Length 12:15Download video MP4
Download video MP3
Similar videos
-
1:13
factors to consider when selecting between continuous and fixed-duration therapy in cll
-
0:57
unanswered questions in frontline cll treatment
-
1:36
selecting the best treatment option in cll
-
1:11
patient selection in the treatment of cll
-
0:49
considering patient preference when selecting between continuous and time-limited therapy in cll
-
1:15
promises and challenges in up-and-coming cll therapies
-
3:34
overcoming the challenges of evolving standards of care in cll: advice for community physicians
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
4:37
impacting cll management with lifestyle modification
-
27:49
what's new with cll treatments w/top expert | dr. william wierda, md anderson | the patient story
-
6:40
from clot to capture: linncing clot composition and clinical outcomes
-
1:27
factors to consider in frontline and relapsed cll before treatment
-
2:46
challenges in the use of btk inhibitors for cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
5:21
examples of biology informing treatment decisions in cll
-
6:41
what are the challenges faced when selecting frontline treatment for cll?
-
2:46
challenges in selecting patients with mf for sct & using ai to determine the optimal timing for sct
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
4:20
selecting the optimal frontline therapy in cll
-
1:36
the importance of genomic testing when making treatment decisions in cll
-
2:30
towards strategies to optimize outcomes in cll
-
1:37
the importance of genomic testing in the diagnosis of cll